Key indicators: single-crystal X-ray study; T = 173 K; mean (C-C) = 0.011 Å; disorder in main residue; R factor = 0.068; wR factor = 0.133; data-to-parameter ratio = 18.2.
The asymmetric unit of the title compound, C 17 H 13 Cl 3 N 4 O 2 Á-0.5C 2 H 6 OS, contains two almost identical molecules and one dimethyl sulfoxide (DMSO-d 6 ) solvent molecule. The pyrazole ring forms dihedral angles of 54.6 (4) and 80.0 (4) in one molecule, and dihedral angles of 54.2 (4) and 81.2 (4) in the other molecule, with the directly attached pyridine and trichlorophenyl rings, respectively. The dihedral angles of the pyridine and trichlorophenyl rings are 51.2 (4) and 52.0 (4) , respectively. The crystal packing is characterized by intra-and intermolecular hydrogen bonds. The crystal is a nonmerohedral twin with a contribution of 0.488 (1) for the minor twin component. The terminal ethyl group of one molecule and the S atom of DMSO are disordered over two sites. 
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Crystal data Table 1 Hydrogen-bond geometry (Å , ). Symmetry codes: (i) x þ 1; y; z; (ii) x; y À 1; z; (iii) x À 1; y À 1; z. BAT thanks the Alexander von Humboldt Foundation for funding.
Pyridin-4-yl substituted five-membered heterocycles have been considered to be potential p38α MAP kinase inhibitors (Abu Thaher et al. 2009; Peifer et al. 2006) . We showed that the regioisomeric switch from 3-(4-fluorophenyl)-4-(pyridin-4-yl)-1-(aryl)-1H-pyrazol-5-amine to 4-(4-fluorophenyl)-3-(pyridin-4-yl)-1-(aryl)-1H-pyrazol-5-amine completely changed the inhibitory profile from p38α MAP kinase to kinases releant in cancer (Abu Thaher, Arnsmann et al. 2012) . Recently, we reported similar crystal structures (Abu Thaher, Koch et al. 2012a,b) .
The asymmetric unit of the title compound contains two almost identical molecules and DMSO-d6 ( 
Figure 1
View of the title compound. Displacement ellipsoids are drawn at the 50% probability level. H atoms are depicted as circles of arbitrary size.
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Figure 2
Crystal structure of the title compound with view along the a-axis. Hydrogen bonding is shown with dashed lines.
Molecule A coloured in black, B in red and DMSO in green. C6A-C1A-C2A 118.1 (7) C8B-N7B-N11B 112.4 (6) C6A-C1A-N7A
121.2 (7) C8B-N7B-C1B 127.1 (6) C2A-C1A-N7A 120.7 (7) N11B-N7B-C1B 120.2 (6) C3A-C2A-C1A 121.5 (7) N12B-C8B-N7B 121.3 (7) C3A-C2A-Cl1A 119.5 (6) N12B-C8B-C9B 132.7 (8) C1A-C2A-Cl1A 119.0 (6) N7B-C8B-C9B 106.0 (6) C4A-C3A-C2A 117.9 (7) C10B-C9B-C8B 104.9 (6) C4A-C3A-H3A
121.0 C10B-C9B-C13B 128.8 (7) C2A-C3A-H3A
121.1 C8B-C9B-C13B 126.0 (7) C3A-C4A-C5A
123.4 (7) N11B-C10B-C9B 113.6 (6) C3A-C4A-Cl2A 119.1 (6) N11B-C10B-C18B 116.4 (7) C5A-C4A-Cl2A 117.4 (6) C9B-C10B-C18B 130.0 (7) C6A-C5A-C4A 117.0 (7) C10B-N11B-N7B 103.1 (6) C6A-C5A-H5A 121.5 C8B-N12B-H12C 111.5 C4A-C5A-H5A 121.5 C8B-N12B-H12D 136.8 C5A-C6A-C1A 122.0 (7) H12C-N12B-H12D 111.7 C5A-C6A-Cl3A 120.3 (6) O14B-C13B-O15B 122.3 (7) C1A-C6A-Cl3A 117.7 (6) O14B-C13B-C9B 125.8 (7) C8A-N7A-N11A
112.6 (6) O15B-C13B-C9B 112.0 (6) C8A-N7A-C1A 127.8 (6) C13B-O15B-C16B 118.5 (6) N11A-N7A-C1A
119.6 (6) O15B-C16B-C17B 111.0 (6) N12A-C8A-N7A 121.7 (7) O15B-C16B-H16C 109.4 N12A-C8A-C9A 131.5 (8) C17B-C16B-H16C 109.4 N7A-C8A-C9A
106.8 (6) O15B-C16B-H16D 109.4 C8A-C9A-C10A 104.8 (7) C17B-C16B-H16D 109.4 C8A-C9A-C13A 128.0 (7) H16C-C16B-H16D 108.0 C10A-C9A-C13A 126.7 (7) C16B-C17B-H17D 109.5 N11A-C10A-C9A 112.5 (7) C16B-C17B-H17E 109.5 N11A-C10A-C18A 117.3 (7) H17D-C17B-H17E 109.5 C9A-C10A-C18A
130.2 (7) C16B-C17B-H17F 109.5 C10A-N11A-N7A
103.4 (6) H17D-C17B-H17F 109.5 C8A-N12A-H12A
128.3 H17E-C17B-H17F 109.5 C8A-N12A-H12B
103.1 C23B-C18B-C19B 116.6 (7) H12A-N12A-H12B
128.6 C23B-C18B-C10B 121.0 (7) O14A-C13A-O15A
123.3 (7) C19B-C18B-C10B 122.4 (7) O14A-C13A-C9A 126.9 (7) C20B-C19B-C18B 119.7 (8) O15A-C13A-C9A
109.8 (6) C20B-C19B-H19B 120.2
